Key statistics
On Thursday, AbbVie Inc (ABBV*:MEX) closed at 3,505.00, -14.10% below its 52-week high of 4,080.50, set on Nov 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3,400.00 |
---|---|
High | 3,505.00 |
Low | 3,400.00 |
Bid | 3,490.00 |
Offer | 3,700.00 |
Previous close | 3,402.00 |
Average volume | 1.96k |
---|---|
Shares outstanding | 1.77bn |
Free float | 1.77bn |
P/E (TTM) | 59.91 |
Market cap | 303.47bn USD |
EPS (TTM) | 2.87 USD |
Annual div (ADY) | 133.97 MXN |
---|---|
Annual div yield (ADY) | 3.80% |
Div ex-date | Oct 15 2024 |
Div pay-date | Nov 15 2024 |
Next div ex-date | Jan 15 2025 |
Next div pay-date | Feb 14 2025 |
Data delayed at least 20 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
Press releases
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- Seaport Therapeutics Names Lauren White as Chief Financial Officer
- NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines